Free shipping on all orders over $ 500

 About 30 results found for searched term "CS1" (0.037 seconds)

Cat.No.  Name Target
M2572 SMI-4a Pim
TCS PIM-1 4a; 327033-36-3
SMI-4a is a potent inhibitor of Pim1 with IC50 of 17 nM, modest potent to Pim-2, does not significantly inhibit other serine/threonine- or tyrosine-kinases.
M2785 JNK Inhibitor IX (SC202671) JNK
TCS JNK 5a; SC-202671
JNK inhibitor IX is a selective and potent JNK inhibitor with pIC50 of 6.5 and 6.7 for JNK2 and JNK3, respectively.
M2956 Pravastatin sodium HMG-CoA Reductase
CS-514 sodium
Pravastatin sodium is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.
M3745 TCS PIM-1 1 Pim
SC 204330
TCS PIM-1 1 is a potent and selective ATP-competitive Pim-1 kianse inhibitor with IC50 of 50 nM, displays good selectivity over Pim-2 and MEK1/MEK2(IC50s > 20,000 nM).
M3760 TCS-1102 OX Receptor
TCS 1102 is a potent, dual orexin receptor antagonist (Ki values are 0.2 and 3 nM for OX2 and OX1 receptors respectively).
M3801 TCS 21311 JAK
TCS 21311 is a potent JAK3 inhibitor with IC50 of 8 nM.
M7381 TCS 1105 Others
TCS 1105 is a gABA A α2 benzodiazepine receptor agonist.
M7382 TCS 1205 Others
TCS 1205 is a subtype-selective GABA A receptor agonist.
M7384 TCS 2314 Integrin
TCS 2314 is a α 4β 1 (VLA-4) antagonist.
M7385 TCS 2510 Prostaglandin Receptor
CAY10598; TCS2510
TCS 2510 is a selective EP4 agonist.
M7387 TCS 5861528 TRP Channel
Chembridge-5861528
TCS 5861528 (Chembridge-5861528) is a potent TRPA1 channel antagonist that antagonizes similarly allyl isothiocyanate- and 4-HNE-evoked TRPA1 responses, with IC50 values of 14.3 μM and 18.7 μM, respectively.
M7397 TCS PrP Inhibitor 13 Others
TCS PrP Inhibitor 13 is a antiprion agent; inhibits PrP Sc accumulation.
M8557 CS1 Others
CS1 is a selective and potent inhibitor of topoisomerase IIα (TopoIIα) that potently inhibits a proliferation of cancer cell lines including MDA-MB-231 and A548 cells, with less toxicity than etoposide.
M8700 PCS1055 dihydrochloride Others
PCS1055 is a potent and selective muscarinic M4 acetylcholine receptor competitive antagonist that exhibits >100-fold selectivity over M1-, M3-, and M5-receptors and 30-fold selectivity at the M2 receptor.
M9412 IACS-10759 Others
Iacs-10759 is a potent inhibitor of the oxidative phosphorylation complex I (OXPHOS).
M9464 Asapiprant Prostaglandin Receptor
S-555739; CS-2811
Asapiprant is a potent and selective DP1 receptor antagonist, with a Ki of 0.44 nM.
M9853 Brepocitinib P-Tosylate JAK
CS-2860; Brepocitinib;PF-06700841 P-Tosylate
PF-06700841 (Brepocitinib) tosylate is a dual inhibitor of JAK1 and TYK2, with IC50 values of 17 nM and 23 nM, respectively.
M10014 Recombinant Murine M-CSF Protein (HEK 293, C-His) Recombinant Proteins
CSF-1; MGI-IM
Recombinant Murine M-CSF Protein (HEK 293) is a powerful hematopoietic factor produced by lymphocytes, monocytes, fibroblasts, endothelial cells, myoblasts and osteoblasts.
M10326 Zuranolone GABA Receptor
SAGE-217; CS-2797; BIIB125
Zuranolone also known as SAGE-217, is a potent GABAA receptor agonist with EC50 values of 296 nM and 163 nM for α1β2γ2 and α4β3δ GABAA receptors.
M10479 Esaxerenone (CS-3150) Mineralocorticoid Receptor
CS-3150; XL-550
Esaxerenone (CS-3150) is a highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
M10513 MA-0204 PPAR
CS-2841; MA0204
MA-0204 is a highly potent and selective PPARδ modulator (PPARδ EC50 = 0.4 nM; PPARα, EC50 = 6,660 nM) that upregulates the expression of FAO genes in human renal proximal tubule cells, resulting in increased mitochondrial fatty acid oxidation.
M10592 Recombinant Human M-CSF (CHO) Recombinant Proteins
Recombinant Human Macrophage Colony-stimulating Factor; CSF-1; rHM-CSF
Human M-CSF protein (CHO) is a hematopoietic growth factor with multiple glycoylation sites, which can affect the survival and function of macrophages and has antitumor activity. It was expressed by CHO cells.
M10738 IACS-13909 Phosphatase
IACS-13909 is a potent selective, orally active SHP2 allosteric inhibitor IC50 for 15.7 nM,Kd 32 nM. IACS-13909 is more selective for SHP2 than other phosphatase, including SHP1. IACS-13909 inhibits the signaling of the receptor tyrosine kinase (RTK)/MAPK pathway and has an anticancer effect.
M10769 CS-2671 Others
TASP0415914 is an effective and orally active PI3Kγ inhibitor,IC50 29 nM.
M10945 Chiauranib VEGFR/PDGFR
CS2164
Chiauranib (CS2164) is a first-in-class orally active multi-target inhibitor of tumor angiogenesis.Chiauranib potently inhibits the angiogenesis-related kinases (VEGFR1, VEGFR2, VEGFR3, PDGFRα and c-Kit), mitosis-related kinase Aurora B and chronic inflammation-related kinase CSF-1R. Chiauranib has strong anticancer activity.
M11268 LSZ-102 Estrogen Receptor
CS-2791
Lsz-102 is a potent, oral bioeffective selective estrogen receptor inhibitor with an IC50 value of 0.2 nM.
M11283 Inolitazone dihydrochloride PPAR
Efatutazone dihydrochloride; CS-7017 dihydrochloride; RS5444 dihydrochloride
Inolitazone dihydrochloride (Efatutazone dihydrochloride) is a PPARγ agonist with high affinity, activity dependent on PPARγ, inhibiting growth, IC50 is 0.8 nM.
M11342 LCS-1 SOD
LCS1
LCS-1 is a superoxide dismutase 1 (SOD1) inhibitor. LCS-1 inhibited SOD1 activity with IC50 value of 1.07 μM. LCS-1 induces early and late apoptosis in multiple myeloma cells (MM.1S).
M11449 AG-024322 COX
CS-1092
Ag-024322 is a potent ATP-competitive pan-CDK inhibitor that inhibits THE Ki values of CDK1, CDK2, and CDK4 in the 1-3 nM range. Ag-024322 showed broad spectrum antitumor activity and clear target regulation in vivo. Ag-024322 induced apoptosis.
M11485 Recombinant Mouse GM-CSF Protein (E. coli) Recombinant Proteins
Granulocyte Macrophage Colony Stimulating Factor; CSF-2; MGI-1GM
Expression system: E. coli Bioactivity: ED50 < 5.0 pg/ mL, measured in cell proliferation assay of mouse FDC-P1 cells, corresponding specific activity > 2.0 × 108 units/mg.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.